Ro takes care of the rest
Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Huang Y, He Y, Makarcyzk MJ, Lin H Frontiers in Bioengineering and Biotechnology (2021) This study demonstrated that FOXO4-DRI selectively removes senescent cells from human chondrocyte cultures expanded in vitro, providing direct evidence of the peptide's senolytic activity in human cells relevant to joint and cartilage aging
A few things: aggressive agitation (shaking), exposure to the wrong pH, or using a non-sterile diluent that introduces contaminants
Patient Eligibility: Your insurance decides if its covered
Ive been using Effecty Health for over a year now, and honestly, its made the process of being on a GLP-1 so much easier
Both medications have well-established safety profiles when used in appropriate doses